Back to search

Article

A novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity

2025-02-08

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> While chimeric antigen receptor (CAR) T cells have achieved encouraging remission rates in hematological malignancies, they demonstrated limited success in treating Glioblastoma (GBM), particularly due to high intra- and intertumoral heterogeneity. In this study, we identified a relevant and preserved target antigen, Podoplanin (PDPN), and evaluated the potential of a PDPN-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
87d16412-ec07-5e29-9404-8634bb3bab38
DOI
10.1101/2025.02.03.636223
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneityDOI 10.1101/2025.02.03.636223
Select a neighboring publication to make it the new centre.